Key Takeaway
MCT supplementation significantly improved memory in Alzheimer's patients without APOE4 gene variant
Summary
This study examined the cognitive effects of MCT-based ketogenic formula in patients with mild-to-moderate Alzheimer's disease, with particular attention to how genetic factors (APOE4 status) influence response to ketogenic interventions.
Methods
- Design: Randomized, double-blind, placebo-controlled crossover trial
- Participants: 20 patients with mild-to-moderate Alzheimer's disease
- Intervention: MCT-based ketogenic formula vs isocaloric placebo
- Duration: 12 weeks per arm with washout period
- Genetic stratification: APOE4 carriers vs non-carriers
Key Results
- MCT intake significantly increased serum ketone bodies
- Significant improvement in immediate and delayed memory in non-APOE4 carriers
- APOE4 carriers showed less response to intervention
- Improved scores on logical memory and digit-symbol coding tests
- Changes correlated with degree of ketone elevation
Limitations
- Small sample size (n=20)
- Short intervention duration (12 weeks)
- Response varies by APOE4 genotype
- May not generalize to healthy populations or prevention contexts
- Japanese population - cultural/dietary factors may influence results